ChartRow logo
ChartRow
Investing Charts
Sign in
EW
Edwards Lifesciences CorporationStock · HealthcareS&P 500 0.1%
$82.64−$1.18 (-1.41%)as of market close, Jul 24, 2026
CompareLLYUNHJNJABBVISRGABT

How Edwards Lifesciences makes money

Period

How does Edwards Lifesciences make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Edwards Lifesciences Corporation · FY2025 · year ended 2025-12-31
Revenue$6.1BGross profit$4.7B · 78%Cost of revenue$1.3B · 22%Operating income$1.3B · 21%Operating expenses$3.5B · 57%R&D$1.1B · 18%SG&A$2.1B · 34%Other opex$305M · 5%Net income$1.1B · 18%Income tax$217M · 4%Transcatheter Aortic Valve Replacement$4.5B · 74%Surgical Heart Valve Therapy$1.0B · 17%Transcatheter Mitral & Tricuspid Therapies$551M · 9%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.